KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Regeneron Pharmaceuticals (REGN) over the last 15 years, with Q4 2025 value amounting to 0.1%.

  • Regeneron Pharmaceuticals' Return on Invested Capital fell 200.0% to 0.1% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.1%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.1% for FY2025, which is 300.0% down from last year.
  • According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Return on Invested Capital is 0.1%, which was down 200.0% from 0.11% recorded in Q3 2025.
  • Regeneron Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.39% for Q4 2021, and its period low was 0.1% during Q4 2025.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.16% (2023), whereas its average is 0.2%.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Return on Invested Capital soared by 1400bps in 2021, and later crashed by -2100bps in 2022.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Return on Invested Capital stood at 0.39% in 2021, then crashed by -55bps to 0.18% in 2022, then fell by -18bps to 0.14% in 2023, then dropped by -16bps to 0.12% in 2024, then decreased by -19bps to 0.1% in 2025.
  • Its Return on Invested Capital stands at 0.1% for Q4 2025, versus 0.11% for Q3 2025 and 0.12% for Q2 2025.